Language Selector

    Innovative Medicines Initiative has launched Call 14

    Published on 21 March 2018
    Author: Sasha Hugentobler, National Contact Point Health, Demographic Change & Wellbeing

    Funding in immune interventions, clinical molecular imaging, machine learning in drug discovery and clinical trials available. 1st stage submission deadline is 14 June 2018.

    The Innovative Medicines Initiative has  launched IMI2 – Call 14 with the following topics:

    • Topic 1: Targeted immune intervention for the management of non-response and relapse
    • Topic 2: Non-invasive clinical molecular imaging of immune cells
    • Topic 3: Development of a platform for federated and privacy-preserving machine learning in support of drug discovery
    • Topic 4: Centre of excellence – remote decentralised clinical trials

    Deadline for submitting proposals: 14 June 2018, 17:00 Brussels time.

    Sign up to / catch up on the IMI2 – Call 14 webinars on all Call topics, plus the rules & procedures and opportunities for small and medium-sized enterprises (SMEs)

    More information